The treatment of pediatric chronic myelogenous leukemia in the imatinib era

Childhood chronic myelogenous leukemia (CML) is a rare hematologic disease, with limited literature on the methods of treatment. Previously, allogeneic hematopoietic stem cell transplantation (HSCT) was considered the only curative treatment for this disease. Treatment with imatinib, a selective inh...

Full description

Bibliographic Details
Main Authors: Jae Wook Lee, Nack Gyun Chung
Format: Article
Language:English
Published: Korean Pediatric Society 2011-03-01
Series:Korean Journal of Pediatrics
Subjects:
Online Access:http://kjp.or.kr/upload/pdf/kjped-54-111.pdf